InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,902.71
(
0.98%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

wjlknew

Send PM Follow Ignore
Followers 1
Posts 219
Boards Moderated 0
Alias Born 03/09/2006

wjlknew

Re: DewDiligence post# 11540

Sunday, 06/08/2008 2:31:03 PM

Sunday, June 08, 2008 2:31:03 PM

Post# of 19309
OK, but I'm a simple guy too so I need a simple definition. How about:

"Biosimilars or Follow-on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products, following patent expiry."

This is from Wiki, so it probably isn't gospel but I can understand it.

I also understand the controversy over data exclusivity, but didn't the Supremes give a way to resolve that to no one's satisfaction ... which is usually the best resolution possible?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up